Long-awaited amendments to Canada’s patent linkage provisions relating to generic and biosimilar market approval have been published. The amendments seek to implement changes agreed to under the Canadian-European, Comprehensive Economic and Trade Agreement (CETA) and address criticisms of the former patent linkage regime. Read more